Polygenic risk scores (PRSs), which often aggregate results from genome-wide association
studies, can bridge the gap between initial discovery efforts and clinical applications for the …

… This burden is even greater for laboratories integrated into healthcare systems, who may
need to interrogate both structured and unstructured information from the electronic medical …

Automated annotation of protein function is challenging. As the number of sequenced
genomes rapidly grows, the overwhelming majority of protein products can only be annotated …

Polygenic diseases, which are genetic disorders caused by the combined action of multiple
genes, pose unique and significant challenges for the diagnosis and management of …

… KCNE1 1 Potassium channel, voltage-gated subfamily E regulatory beta subunit 1 Ion …
multiple VOIs and extensive LVNC presented with severe LV systolic dysfunction (E and F). …

Purpose Discovering an incidental finding (IF) or secondary finding (SF) is a potential result
of genomic testing, but few data exist describing types and frequencies of SFs likely to …

The advancement of precision medicine requires new methods to coordinate and deliver
genetic data from heterogeneous sources to physicians and patients. The eMERGE III Network …

Purpose The Mayo-Baylor RIGHT 10K Study enabled preemptive, sequence-based
pharmacogenomics (PGx)-driven drug prescribing practices in routine clinical care within a large …

Harmonization of variant pathogenicity classification across laboratories is important for
advancing clinical genomics. The two CLIA-accredited Electronic Medical Record and Genomics …

Importance Knowledge about the spectrum of diseases associated with hereditary cancer
syndromes may improve disease diagnosis and management for patients and help to identify …